Tomorrow, enGene will be at European Association of Urology (EAU) 2025 in Madrid, Spain to present a trial-in-progress update on our LEGEND trial in patients with high-risk, non-muscle invasive bladder cancer (NMIBC). Attending? Join us for this session presented by Félix Guerrero Ramos MD PhD FEBU.
